14 completed, 8 recruiting, 5 active not recruiting, 2 not yet recruiting. 12 Phase 2, 11 Not applicable, 5 Phase 1, 1 Early Phase 1, 1 Phase 3.
Follow DCIS: new trials by email Literature Review of DCIS trials Research Report on DCIS
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Prospective CohorT Study of HandX - Assisted ENdoscopic MAstectomy: Feasibility and Safety (ATHENA I Study) Endoscopic nipple sparing mastectomy, HandX endoscopic instrument - Breast Cancer, BRCA 1 Gene Mutation | Not applicable | Recruiting | Vasileios Kalles | 15 | 2025-09-09 | 2025-12-18 |
| Pilot Trial of Preop Partial Radiation in Breast Cancer Patients Radiation: Accelerated Partial Breast Irradiation (APBI) - Early-stage Breast Cancer, Breast Carcinoma | Phase 1 | Suspended | Rutgers, The State University of New Jersey | 98 | 2025-09-02 | 2025-11-14 |
| Robotic Nipple Sparing Mastectomy with Immediate Reconstruction Robotic Nipple-Sparing Mastectomy - Breast Cancer, DCIS | Not applicable | Not yet recruiting | European Institute of Oncology | 24 | 2025-04-01 | 2025-03-05 |
| The Added Value of Contrast Enhanced Mammography to Standard Mammography in Assessing the Extent of DCIS Contrast Enhanced Mammography - DCIS, Breast Carcinoma in Situ | Not applicable | Not yet recruiting | Clinical Hospital Center Rijeka | 100 | 2025-03-01 | 2025-01-06 |
| Ultra Hypo-fractionated Adjuvant Whole Breast Radiation Therapy With Simultaneous Integrated Boost for Early-Stage Breast Cancer (H-ASSIST) Breast Radiotherapy - Breast Cancer, Early-stage Breast Cancer | Phase 2 | Recruiting | UNC Lineberger Comprehensive Cancer Center | 90 | 2025-02-19 | 2026-09-03 |
| THRIVE Study: Positive Affect Training for Endocrine Therapy Medication Adherence THRIVE Online PAT Program - Breast Cancer, DCIS | Not applicable | Completed | Joanna Arch | 39 | 2024-03-12 | 2026-01-21 |
| LS301-IT in Partial Mastectomy and Sentinel Lymph Node Biopsy (SLNB) for DCIS or Stage I-II Primary Invasive Breast Cancer LS301-IT 0.025 mg/kg, LS301-IT 0.05 mg/kg, LS301-IT 0.075 mg/kg - Breast Cancer, DCIS | Phase 1 / Phase 2 | Completed | Integro Theranostics | 22 | 2023-07-14 | 2026-05-20 |
| Delayed Selective Sentinel Node Biopsy for Patients Undergoing Mastectomy for DCIS Delay sentinel node biopsy - DCIS | Not applicable | Recruiting | Seoul National University Hospital | 84 | 2023-06-13 | 2025-01-31 |
| Prospective Evaluation of Breast-Conserving Surgery Alone in Low-Risk Ductal Carcinoma in Situ (DCIS) DCIS | Active not recruiting | Ontario Clinical Oncology Group (OCOG) | 526 | 2022-11-23 | 2026-10-05 | |
| Partial Chest Wall Radiation Therapy After Surgery for Lymph Node Negative Breast Cancer Partial Chest Wall Radiation Therapy - Breast Cancer, Breast Cancer Female | Early Phase 1 | Withdrawn | Stony Brook University | 2022-07-15 | 2023-10-18 | |
| Real-Time MRI-Guided 3-Fraction Accelerated Partial Breast Irradiation in Early Breast Cancer MRIdian Radiation Treatment Unit - Breast Cancer, DCIS | Phase 2 | Recruiting | University of Wisconsin, Madison | 30 | 2022-05-16 | 2026-06-11 |
| The AUS-PREDICT Registry for DCIS Patients With DCISionRT Testing DCISionRT Test - DCIS | Active not recruiting | PreludeDx | 1500 | 2021-07-02 | 2026-04-03 | |
| Molecular Analysis of the Sloane Project DCIS, LCIS | Unknown | King's College London | 1500 | 2020-03-01 | 2023-05-22 | |
| Delayed Sentinel Lymph Node Biopsy in Ductal Cancer in Situ Delayed SLND, Late SLND - DCIS, Breast Cancer | Phase 3 | Recruiting | Uppsala University | 500 | 2020-03-01 | 2023-08-03 |
| Pilot Study of a an App to Improve Medication Adherence in Breast Cancer Survivors Receiving AIs LifeExtend-AI - Breast Cancer, DCIS | Not applicable | Completed | Indiana University | 62 | 2020-02-17 | 2022-09-14 |
| Genotype and Phenotype Guided Supplementation of TAMoxifen Standard Therapy With ENDOXifen in Breast Cancer Patients (Z)-Endoxifen supplementation according to genotype, (Z)-Endoxifen supplementation according to plasma levels - Breast Cancer, DCIS | Phase 2 | Completed | Robert Bosch Gesellschaft für Medizinische Forschung mbH (RBMF) | 356 | 2019-09-10 | 2021-09-17 |
| Study of 3-Day Partial Breast Radiation Therapy in Women With Breast Cancer Accelerated Partial Breast Irradiation - Invasive Ductal Breast Carcinoma, Invasive Ductal Carcinoma, Breast | Phase 2 | Recruiting | Memorial Sloan Kettering Cancer Center | 280 | 2019-08-30 | 2026-09-21 |
| Perioperative Mindfulness Proposal Meditation - Breast Cancer, DCIS | Not applicable | Recruiting | Hoag Memorial Hospital Presbyterian | 24 | 2019-07-31 | 2024-10-15 |
| Radiotherapy Omission in Low Risk Ductal in Situ Carcinoma Breast Radiotherapy, No Radiotherapy - DCIS, Breast Cancer | Not applicable | Active not recruiting | UNICANCER | 295 | 2019-05-10 | 2026-01-23 |
| Assessing the Impact of the Microbiome on Breast Cancer Radiotherapy Toxicity Stool sample, Skin Swab Sample - DCIS, Invasive Breast Cancer | Completed | Case Comprehensive Cancer Center | 23 | 2019-03-21 | 2024-09-19 |
Showing 20 of 34. Sign in to see all of them.
Carcinoma, Intraductal, Noninfiltrating (34) · Breast Neoplasms (20) · Breast Carcinoma In Situ (2) · Carcinoma, Ductal, Breast (2) · Breast Cancer, Familial (1) · Calcinosis (1) · Carcinoma, Ductal (1) · Neoplasms (1)
Adenocarcinoma (34) · Carcinoma (34) · Carcinoma in Situ (34) · Neoplasms by Histologic Type (34) · Neoplasms, Ductal, Lobular, and Medullary (34) · Neoplasms, Glandular and Epithelial (34) · Neoplasms (33) · Breast Carcinoma In Situ (32) · Breast Diseases (22) · Neoplasms by Site (22) · Skin Diseases (22) · Skin and Connective Tissue Diseases (22) · Breast Neoplasms (2) · Carcinoma, Ductal (2) · Calcium Metabolism Disorders (1)
Radiotherapy (2) · Anastrozole (1) · Biopsy (1) · Chloroquine (1) · Mammography (1) · Meditation (1) · Observation (1) · Surgical Procedures, Operative (1) · palbociclib (1)
Ontario Clinical Oncology Group (OCOG) (3) · Dana-Farber Cancer Institute (2) · Georgetown University (2) · PreludeDx (2) · Abramson Cancer Center at Penn Medicine (1) · Alliance Foundation Trials, LLC. (1) · Case Comprehensive Cancer Center (1) · Clinical Hospital Center Rijeka (1) · European Institute of Oncology (1) · Hoag Memorial Hospital Presbyterian (1) · Hologic, Inc. (1) · Indiana University (1) · Inova Health Care Services (1) · Integro Theranostics (1) · Joanna Arch (1)
United States (22) · Canada (3) · Australia (1) · Croatia (1) · France (1) · Germany (1) · Greece (1) · Hong Kong (1) · Italy (1) · Netherlands (1) · South Korea (1) · Sweden (1) · United Kingdom (1)
Eileen Rakovitch, M.D. (2) · Alastair Thompson, MD (1) · Alexander Stessin, MD PhD (1) · Andreas Karakatsanis, PhD (1) · Ann Partridge, MD, MPH (1) · Atif J Khan, MD (1) · Bethany Anderson, MD (1) · Brian J Czerniecki, M.D., Ph.D. (1) · Candace Mainor, MD (1) · Chirag Shah, MD (1) · Dan Thompson (1) · Do-Hoon Kim, MD (1) · Elinor Sawyer (1) · Eric Winer, MD (1)
PMID 20562526, PMID 30862637, PMID 32350679, PMID 33997922, PMID 37296810, PMID 38916700, PMID 39289750, PMID 39378393, PMID 39665585, PMID 39665588, PMID 42649946
2016 (1)